The US Is Paying Way Too Much for Remdesivir
by Rohan Chalasani, Walid Gellad from Feed: All Latest on (#55TXC)
The inflated price of the anti-Covid drug may not bother hospitals, insurance companies, or even patients. But it's still not justified.